Automated Author ProfileC., Long
C., Long
Current S-Index
Sum of Dataset Indices for all datasets
Average Dataset Index per Dataset
Average Dataset Index per dataset
Total Datasets
Total datasets for this author
Average FAIR Score
Average FAIR Score per dataset
Total Citations
Total citations to the author's datasets
Total Mentions
Total mentions of the author's datasets
S-Index Interpretation
The S-Index (Sharing Index) is a comprehensive metric that represents the cumulative impact of all your datasets. It is calculated as the sum of Dataset Index scores across all your claimed datasets.
What it means:
- A higher S-index indicates greater overall impact of your datasets relative to typical datasets in their fields of research
- The S-Index grows as you add more datasets or as existing datasets gain more citations and mentions
- It provides a single number to track your research data impact over time
Current S-Index: 3.0 (sum of 2 datasets Dataset Index scores)
More information here.
S-Index Over Time
Cumulative Citations Over Time
Cumulative Mentions Over Time
Datasets
Introduction： The role of endovascular thrombectomy (EVT) for acute extra-large ischemic stroke patients with large vessel occlusion (LVO) is uncertain. We aimed to explore the clinical and safety outcomes of medical management (MM) plus EVT (EVT group) versus MM alone (MM group) among acute extra-large ischemic stroke patients with LVO within 24 hours of last known well.Methods： XL STROKE (endovascular thrombectomy for extra-large ischemic stroke) is an investigator-initiated, nationwide, prospective registry with blinded end point assessment performed at approximately 60 sites in China, and will enroll up to 990 acute ischemic stroke patients within 24 hours of last known well. Imaging inclusion criteria are occlusion of the internal carotid artery, or the middle cerebral artery M1 or M2 segments, and Alberta Stroke Program Early Computed Tomography Score of 0 to 2 or an ischemic-core volume ≥85ml. All patients will be dichotomized into EVT group and MM group according to whether they received EVT or not. The primary outcome is the level of disability on the modified Rankin Scale at 90±14 days. Safety outcomes include symptomatic intracranial hemorrhage within 48 hours, and mortality at 90±14 days. Conclusion： Results from XL STROKE registry will provide constructive evidence of improved disability outcomes and safety with EVT for acute extra-large ischemic stroke patients with LVO within 24 hours of last known well. Trial registrations: ClinicalTrials.gov, NCT06210633
Authors
- karger, figshare admin ;
- G., Yuan ;
- L., Liu ;
- Y., Liang ;
- J., Wu ;
- T.N., Nguyen ;
- S., Wei ;
- T., Cui ;
- X., Li ;
- Z., Yuan ;
- S., Liu ;
- G., Zeng ;
- Z., Ruan ;
- C., Zheng ;
- X., Tan ;
- S., Tang ;
- H., Hao ;
- H., Xia ;
- R.G., Nogueira ;
- G., Thomalla ;
- B., Campbell ;
- J.L., Saver ;
- Q., Yang ;
- C., Long ;
- Z., Qiu ;
- H., Sang ;
- investigators, On behalf of the XL STROKE
Introduction： The role of endovascular thrombectomy (EVT) for acute extra-large ischemic stroke patients with large vessel occlusion (LVO) is uncertain. We aimed to explore the clinical and safety outcomes of medical management (MM) plus EVT (EVT group) versus MM alone (MM group) among acute extra-large ischemic stroke patients with LVO within 24 hours of last known well.Methods： XL STROKE (endovascular thrombectomy for extra-large ischemic stroke) is an investigator-initiated, nationwide, prospective registry with blinded end point assessment performed at approximately 60 sites in China, and will enroll up to 990 acute ischemic stroke patients within 24 hours of last known well. Imaging inclusion criteria are occlusion of the internal carotid artery, or the middle cerebral artery M1 or M2 segments, and Alberta Stroke Program Early Computed Tomography Score of 0 to 2 or an ischemic-core volume ≥85ml. All patients will be dichotomized into EVT group and MM group according to whether they received EVT or not. The primary outcome is the level of disability on the modified Rankin Scale at 90±14 days. Safety outcomes include symptomatic intracranial hemorrhage within 48 hours, and mortality at 90±14 days. Conclusion： Results from XL STROKE registry will provide constructive evidence of improved disability outcomes and safety with EVT for acute extra-large ischemic stroke patients with LVO within 24 hours of last known well. Trial registrations: ClinicalTrials.gov, NCT06210633
Authors
- karger, figshare admin ;
- G., Yuan ;
- L., Liu ;
- Y., Liang ;
- J., Wu ;
- T.N., Nguyen ;
- S., Wei ;
- T., Cui ;
- X., Li ;
- Z., Yuan ;
- S., Liu ;
- G., Zeng ;
- Z., Ruan ;
- C., Zheng ;
- X., Tan ;
- S., Tang ;
- H., Hao ;
- H., Xia ;
- R.G., Nogueira ;
- G., Thomalla ;
- B., Campbell ;
- J.L., Saver ;
- Q., Yang ;
- C., Long ;
- Z., Qiu ;
- H., Sang ;
- investigators, On behalf of the XL STROKE